.fusion-header-wrapper { padding-top: 0px;background: #000dbb !important;} #page-header { display:none;} .fusion-header-wrapper.fusion-is-sticky { visibility: visible;}.post-content {padding-top: 30px;}
/* CSS to help with ACF styling */ .fusion-logo img { opacity: 0; } .fusion-main-menu > ul > li > a { border-color: #444; } .fusion-logo-link { background: url(https://www.fairwarning.com/wp-content/themes/Avada-Child-Theme/images/dark-logos2.png); } .fusion-main-menu .fusion-main-menu-icon:after, .fusion-main-menu .fusion-widget-cart-counter > a:before { color: #696969; } .fusion-header { background-color: #fff !important; } .fusion-header-wrapper { padding-top: 0px; background: #ffffff !important; } .fusion-is-sticky .fusion-main-menu > ul > li > a { font-size: 14px; } .fusion-main-menu > ul > li > a, .fusion-main-menu > ul > li > a .fusion-menu-description { color: #444 !important; } .fusion-main-menu > ul > li > a:hover { color: #444 !important; font-weight: bold; } .fusion-body .fusion-main-menu .current-menu-parent > a { color: #444 !important; font-weight: bold !important; }
/* CSS to help with ACF styling */ #page-header .h1 {color: #444;} #page-header h2.text-color-xsdn-color {color: #444;}
/* CSS to help with ACF styling */ #page-header .h1 {color: #fff;} #page-header h2.text-color-xsdn-color {color: #fff;}
/* CSS to help with ACF styling */ #page-header .h1 {color: ;} #page-header h2.text-color-xsdn-color {color: ;}
/* CSS to help with ACF styling */ #page-header {background-color: #031ac3;}
/* CSS to help with ACF styling */ #page-header {background-color: #fff;}
/* CSS to help with ACF styling */ #page-header {background-color: #fff;}
/* CSS to help with ACF styling */ #page-header {background: #fff url() center center; padding-top: 0px; padding-bottom: 0px; } @media all and (max-width: 4699px) and (min-width: 1925px) { .title-and-subtitle-background-image { padding-top: 3% !important; padding-bottom: 3% !important; } }
/* CSS to help with ACF styling */ #page-header {background: ;}
FairWarning

Trent Long

Director of MPS

Trent Long, FairWarning Director of Managed Privacy ServicesPDE

John J. Burke

President/Owner

John Burke, president and owner of Pharmaceutical Diversion Education, discusses drug diversion in healthcare

Thursday, October 11 | 2:00 PM EDT

Addressing Drug
Diversion in Healthcare:
Where Do I Start?

FairWarning Executive Series Webinar

Addressing Drug Diversion in HealthcareAddressing Drug Diversion in Healthcare

Drug diversion has surged in healthcare in recent years, creating hefty impacts for both patients and care providers. This is fueled largely by the opioid epidemic which claimed over 49,000 deaths last year – a 410% increase from 2002.

Patient safety is the number one concern for care providers surrounding drug diversion.  Further Impacts to care providers come in the form of health and safety concerns, regulatory liability, mandated participation in federally sponsored programs, financial loss, unwanted media attention, and a breakdown of trust between patient and provider. 

The Department of Justice and the U.S. Drug Enforcement Administration are pouring vast resources into tackling the growing problem of drug diversion. Efforts include diversion investigators, intelligence research specialists and special agents who have spearheaded over 54 enforcement actions and 283 administrative actions so far this year.

This leaves care providers with the complex task of creating a comprehensive drug diversion monitoring program. But the burning question for many care providers is “Where do I start?” and “What do I do If I catch drug diversion in my facility?”

There are steps care providers can take to detect, investigate, mitigate and remediate incidents of drug diversion. By doing so, they can help ensure trust between patient and provider.

In this webinar you will learn:

  • About emerging trends care providers are facing regarding patient safety concerns
  • How to start and implement a full-lifecycle drug diversion monitoring program
  • What to do once you catch instances of drug diversion
  • How to create a culture of drug diversion compliance and trust
Speakers
John Burke, president and owner of Pharmaceutical Diversion Education, discusses drug diversion in healthcare

Commander John Burke
President/Owner
Pharmaceutical Diversion Education Inc

Commander John J. Burke has been a law enforcement officer for over 49 years. He spent 32 years with the Cincinnati Police Department, the last nine years he formed and was in charge of the department’s Pharmaceutical Diversion Squad. Commander Burke is also the past national president of the National Association of Drug Diversion Investigators (NADDI) and is president and owner of Pharmaceutical Diversion Education Inc. He writes a monthly column on prescription drug abuse in Pharmacy Times magazine, and he recently became the co-founder and President of the International Health Facility Diversion Association (IHFDA), www.ihfda.org  a non-profit, 501C-3 organization dedicated toward the problems surrounding drug diversion within healthcare facilities.
Trent Long, FairWarning Director of Managed Privacy Services

Trent J. Long
Director of Managed Privacy Services
FairWarning

Trent Long is the Director of Managed Privacy Services at FairWarning, a global leader in application security intelligence solutions. FairWarning protects patient information in Electronic Health Records for over 8,500 hospitals and clinics around the world as well as confidential information in financial services companies with over $750 Billion in assets. Trent directs that Managed Privacy Services (MPS) department which is the largest team of certified privacy and security experts in healthcare. The MPS team monitors over 3,000 healthcare facilities and 700,000 employees, handling instances of drug diversion, identity theft, cybersecurity attacks, and fraud.